| Abstrakt: |
Background: Totally implantable venous access devices (TIVADs) are considered a standard of care for administration of intravenous (IV) chemotherapeutic drugs in most centers, especially for patients needing long term chemotherapy which aims to achieve easy, painless, and secure venous access. It can reduce the apprehension and anxiety associated with IV access that increases with each chemotherapy. Methods: This prospective study was conducted at KIMSDU Karad, in patients diagnosed with breast cancer. Our primary aim was to assess the morbidity and patient satisfaction of chemotherapy administration via chemoport and comparing it with patients receiving chemotherapy through peripheral venous access. Results: We observed that chemoport insertion through subclavian vein showed more complications compared to internal jugular vein which included blockage and port site infection. However, patients receiving chemotherapy by chemoport showed better satisfaction as it avoided multiple pricks, discomfort, pain, redness or arm edema associated with peripheral IV line. Conclusion: We concluded that satisfaction rate was higher in patients using chemoport for chemotherapy-as it speeded up the sessions, was less painful and only few people felt its presence affecting cosmesis/day to day activities. [ABSTRACT FROM AUTHOR] |
